Redox Biology
Abstract
Glucokinase-maturity onset diabetes of the young (GCK-MODY) represents a rare genetic disorder due to mutation in the glucokinase (GCK) gene. The low incidence of vascular complications in GCK-MODY makes it a natural paradigm for interrogating molecular mechanisms promoting vascular health under prolonged hyperglycemia. Clinical rate of misdiagnosis has remained high, and a reliable serum lipid biomarker that precedes genetic screening can facilitate correct diagnosis and treatment. Herein, we comprehensively quantitated 565 serum lipids from 25 classes in 105 subjects (42 nondiabetic controls, 30 GCK-MODY patients, 33 drug-na？ve, and newly-onset T2D patients). At false-discovery rate (FDR) <0.05, several phosphatidylcholines (PCs) and plasmalogen PCs were specifically increased in GCK-MODY, while triacylglycerols (TAGs) and diacylglycerols (DAGs) were reduced. Correlation matrices between lipids uncovered coregulation between plasmalogen PCs (PCps) and glycerolipid precursors was distinctly enhanced in GCK-MODY compared to T2D. Strengthened positive correlations between serum PCps and circulating HDLs was specifically observed in hyperglycemic subjects (i.e. T2D and GCK-MODY) compared to normglycemic controls, suggesting that HDL-PCps may elicit distinct physiological effects under hyperglycemia. Amongst GCK-MODY patients, individuals harboring variants ofGCKmutations with elevated PCps also exhibited higher HDLs. Isolated HDLs displayed localized increases (p<0.05) in very-long-chain PUFA-PCs and PCps in GCK-MODY. Protein analyses revealed elevated levels of HDL-resident ATGL (P=0.003) and CEPT1 (P<0.0001), which mediate critical steps of PCps production along the TAG-DAG-PC axis, in GCK-MODY relative to T2D. A panel of four lipids differentiated GCK-MODY from T2D with AUC of 0.950 (95% CI 0.903-9.997). This study provides the first evidence that enhanced recruitment of CEPT1 and ATGL onto HDLs essentially underlie the atheroprotective profiles associated with GCK-MODY. Resultant increases in the production of HDL-PCps and PUFA-PCs provides an active, circulating form of protection towards the vasculature of GCK-MODY, thereby lowering the incidence of vascular complications despite chronic exposure to hyperglycemia since birth.
| 论文编号: | DOI:10.1016/j.redox.2021.101855 |
| 论文题目: | Localized Increases in CEPT1 and ATGL Elevate Plasmalogen Phosphatidylcholines in HDLs Contributing to Atheroprotective Lipid Profiles in Hyperglycemic GCK-MODY |
| 英文论文题目: | Localized Increases in CEPT1 and ATGL Elevate Plasmalogen Phosphatidylcholines in HDLs Contributing to Atheroprotective Lipid Profiles in Hyperglycemic GCK-MODY |
| 第一作者: | Xiaojing Wang, Sin Man Lam, Mingjun Cao,Tong Wang, , Zhixin Wang, Miao Yu, Bowen Li,Huabing Zhang, Fan Ping, Guangyao Song, Kai Feng, Qian Zhang, Jianping Xu, Liyuan Zhou, Mingqun Deng, Xiao Zhai, Xinhua Xiao, Guanghou Shui |
| 英文第一作者: | Xiaojing Wang, Sin Man Lam, Mingjun Cao,Tong Wang, , Zhixin Wang, Miao Yu, Bowen Li,Huabing Zhang, Fan Ping, Guangyao Song, Kai Feng, Qian Zhang, Jianping Xu, Liyuan Zhou, Mingqun Deng, Xiao Zhai, Xinhua Xiao, Guanghou Shui |
| 联系作者: | |
| 英文联系作者: | |
| 外单位作者单位: | |
| 英文外单位作者单位: | |
| 发表年度: | 2021-01-08 |
| 卷: | |
| 期: | |
| 页码: | |
| 摘要: | Glucokinase-maturity onset diabetes of the young (GCK-MODY) represents a rare genetic disorder due to mutation in the glucokinase (GCK) gene. The low incidence of vascular complications in GCK-MODY makes it a natural paradigm for interrogating molecular mechanisms promoting vascular health under prolonged hyperglycemia. Clinical rate of misdiagnosis has remained high, and a reliable serum lipid biomarker that precedes genetic screening can facilitate correct diagnosis and treatment. Herein, we comprehensively quantitated 565 serum lipids from 25 classes in 105 subjects (42 nondiabetic controls, 30 GCK-MODY patients, 33 drug-na？ve, and newly-onset T2D patients). At false-discovery rate (FDR) <0.05, several phosphatidylcholines (PCs) and plasmalogen PCs were specifically increased in GCK-MODY, while triacylglycerols (TAGs) and diacylglycerols (DAGs) were reduced. Correlation matrices between lipids uncovered coregulation between plasmalogen PCs (PCps) and glycerolipid precursors was distinctly enhanced in GCK-MODY compared to T2D. Strengthened positive correlations between serum PCps and circulating HDLs was specifically observed in hyperglycemic subjects (i.e. T2D and GCK-MODY) compared to normglycemic controls, suggesting that HDL-PCps may elicit distinct physiological effects under hyperglycemia. Amongst GCK-MODY patients, individuals harboring variants ofGCKmutations with elevated PCps also exhibited higher HDLs. Isolated HDLs displayed localized increases (p<0.05) in very-long-chain PUFA-PCs and PCps in GCK-MODY. Protein analyses revealed elevated levels of HDL-resident ATGL (P=0.003) and CEPT1 (P<0.0001), which mediate critical steps of PCps production along the TAG-DAG-PC axis, in GCK-MODY relative to T2D. A panel of four lipids differentiated GCK-MODY from T2D with AUC of 0.950 (95% CI 0.903-9.997). This study provides the first evidence that enhanced recruitment of CEPT1 and ATGL onto HDLs essentially underlie the atheroprotective profiles associated with GCK-MODY. Resultant increases in the production of HDL-PCps and PUFA-PCs provides an active, circulating form of protection towards the vasculature of GCK-MODY, thereby lowering the incidence of vascular complications despite chronic exposure to hyperglycemia since birth. |
| 英文摘要: | Glucokinase-maturity onset diabetes of the young (GCK-MODY) represents a rare genetic disorder due to mutation in the glucokinase (GCK) gene. The low incidence of vascular complications in GCK-MODY makes it a natural paradigm for interrogating molecular mechanisms promoting vascular health under prolonged hyperglycemia. Clinical rate of misdiagnosis has remained high, and a reliable serum lipid biomarker that precedes genetic screening can facilitate correct diagnosis and treatment. Herein, we comprehensively quantitated 565 serum lipids from 25 classes in 105 subjects (42 nondiabetic controls, 30 GCK-MODY patients, 33 drug-na？ve, and newly-onset T2D patients). At false-discovery rate (FDR) <0.05, several phosphatidylcholines (PCs) and plasmalogen PCs were specifically increased in GCK-MODY, while triacylglycerols (TAGs) and diacylglycerols (DAGs) were reduced. Correlation matrices between lipids uncovered coregulation between plasmalogen PCs (PCps) and glycerolipid precursors was distinctly enhanced in GCK-MODY compared to T2D. Strengthened positive correlations between serum PCps and circulating HDLs was specifically observed in hyperglycemic subjects (i.e. T2D and GCK-MODY) compared to normglycemic controls, suggesting that HDL-PCps may elicit distinct physiological effects under hyperglycemia. Amongst GCK-MODY patients, individuals harboring variants ofGCKmutations with elevated PCps also exhibited higher HDLs. Isolated HDLs displayed localized increases (p<0.05) in very-long-chain PUFA-PCs and PCps in GCK-MODY. Protein analyses revealed elevated levels of HDL-resident ATGL (P=0.003) and CEPT1 (P<0.0001), which mediate critical steps of PCps production along the TAG-DAG-PC axis, in GCK-MODY relative to T2D. A panel of four lipids differentiated GCK-MODY from T2D with AUC of 0.950 (95% CI 0.903-9.997). This study provides the first evidence that enhanced recruitment of CEPT1 and ATGL onto HDLs essentially underlie the atheroprotective profiles associated with GCK-MODY. Resultant increases in the production of HDL-PCps and PUFA-PCs provides an active, circulating form of protection towards the vasculature of GCK-MODY, thereby lowering the incidence of vascular complications despite chronic exposure to hyperglycemia since birth. |
| 刊物名称: | Redox Biology |
| 英文刊物名称: | Redox Biology |
| 论文全文: | |
| 英文论文全文: | |
| 全文链接: | |
| 其它备注: | Xiaojing Wang, Sin Man Lam, Mingjun Cao,Tong Wang, , Zhixin Wang, Miao Yu, Bowen Li,Huabing Zhang, Fan Ping, Guangyao Song, Kai Feng, Qian Zhang, Jianping Xu, Liyuan Zhou, Mingqun Deng, Xiao Zhai, Xinhua Xiao, Guanghou Shui. Localized Increases in CEPT1 and ATGL Elevate Plasmalogen Phosphatidylcholines in HDLs Contributing to Atheroprotective Lipid Profiles in Hyperglycemic GCK-MODY. Redox Biology. DOI:10.1016/j.redox.2021.101855 |
| 英文其它备注: | |
| 学科: | |
| 英文学科: | |
| 影响因子: | |
| 第一作者所在部门: | |
| 英文第一作者所在部门: | |
| 论文出处: | |
| 英文论文出处: | |
| 论文类别: | |
| 英文论文类别: | |
| 参与作者: | |
| 英文参与作者: |
